Research Interests
The research interest of our laboratory mainly focuses on understanding the biochemical and molecular mechanisms of estrogen's hormonal and carcinogenic actions. In recent years, we have systematically characterized the complete profiles of various biologically-active estrogen metabolites/derivatives that are formed by various human cytochrome P450 isoforms or in various human tissues (hepatic and extrahepatic). In addition, we have also been studying the unique biological functions associated with some of the bioactive estrogen metabolites (such as 2-methoxyestradiol and 4-hydroxyestradiol) in selected target sites. Major efforts are currently underway to identify novel estrogen receptors that are believed to mediate the unique biological actions of some estrogen metabolites.
In addition, our laboratory have also been developing novel theories and mechanistic hypotheses for the better understanding of the therapeutic/toxic actions/effects of some commonly-used drugs, and also for the better understanding of the pathogenic mechanisms underlying a number of important human diseases, such as Parkinson’s disease, spongiform encephalopathies (also called "prion diseases"), and hyperhomocysteinemia-associated diseases.
Selected Recent Publications (most recent first):
Zhu BT, Shim JY, Nagai M and Bai HW [2008] Molecular modelling study of the mechanism of high-potency inhibition of human catechol-O-methyltransferase by (-)-epigallocatechin-3-O-gallate. Xenobiotica 38: 130-146.
Ding J and Zhu BT [2008] Unique effect of the pregnancy hormone estriol on antigen-induced production of specific antibodies in female BALB/c mice. Steroids 73: 289-298.
Zhu BT, Gallo MA, Burger CW, Meeker RJ, Cai MX, Xu S and Conney AH [2008] Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin administration and high-fat diet on the body weight and hepatic estrogen metabolism in female C3H/HeN mice. Toxicology and Applied Pharmacology 226: 107-118.
Zhu BT [2008] Is it necessary to control the level of estrogen receptor α and β activation in postmenopausal hormone replacement therapy in order to achieve the optimal outcomes? Molecular Medicine Reports 1: 15-20.
Zhou R, Lai Y and Zhu BT [2008] Estriol has distinctly different effects from 17β-estradiol in modulating mouse splenocyte functions under naïve or inflammatory conditions. Journal of Immunology.
Fukui M, Song J and Zhu BT [2008] Mechanism of 2-methoxyestradiol-induced apoptosis and growth arrest in human breast cancer cells. Molecular Carcinogenesis.
Jiang XR, Wang P, Fu X and Zhu BT [2008] Chemical synthesis and biochemical characterization of biotinylated derivatives of 17β-estradiol with a long side-chain covalently attached to its C-7α position. Steroids.
Bai HW, Wang P and Zhu BT [2008] Identification and characterization of a novel haplotype of the human catechol-O-methyltransferase gene. Pharmacogenetics and Genomics.
Mills LH, Yu J, Xu XM, Lee AJ and Zhu BT [2008] Naturally-occurring estradiol-17beta-fatty acid esters, but not estradiol-17beta, preferentially induce mammary tumorigenesis in female ACI rats. Cancer Research.
Takemura H, Shim JY, Sayama K, Tsubura A, Zhu BT and Shimoi K [2007] Characterization of the estrogenic activities of Zearalenone and Zeranol in vivo and in vitro. Journal of Steroid Biochemistry and Molecular Biology 103: 170-177.
Bai H, Shim JY and Zhu BT [2007] Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases. Chemical Research in Toxicology 20: 1409-1425.
Chen AY, Lee AJ, Jiang XR and Zhu BT [2007] Chemical synthesis of six novel 17β-estradiol and estrone dimers and confirmation of their formation catalyzed by human liver microsomes and cytochrome P450 isoforms. Journal of Medicinal Chemistry 50: 5372-5381.
Bai HW and Zhu BT [2007] Activation of cyclooxygenase I and II by bioflavonoids. Submitted.
Zhu BT [2006] Roles of CNS oxidation and methylation of dopamine neurotransmitter in Parkinson's disease. In: Focus on Parkinson's Disease Research. Editor: Marianne J. Willow, Nova Publishers, pp. 21-43.Contact Information:
Bao Ting Zhu, Ph.D.
Professor
Department of Pharmacology, Toxicology, & Therapeutics
The University of Kansas Medical Center
MS 1018, KLSIC 4061
3901 Rainbow Blvd.
Kansas City, KS 66160
Phone: (913) 588-9842
Fax: (913) 588-7501
E-mail address: btzhu@kumc.edu
Updated 02/15/2007
